Skip to main content
Top
Published in: Rheumatology International 7/2021

01-07-2021 | ANCA-Associated Vasculitis | Case Based Review

IgA nephropathy with serum ANCA positivity: case series and literature review

Authors: Gabriel Ștefan, George Terinte-Balcan, Simona Stancu, Adrian Zugravu, Mihaela Gherghiceanu, Gabriel Mircescu

Published in: Rheumatology International | Issue 7/2021

Login to get access

Abstract

The co-occurrence of IgA nephropathy (IgAN) and positive anti-neutrophil cytoplasmic autoantibodies (ANCA) serology is uncommon. In the present case series and literature review, we aimed to clarify the impact of ANCA on pathogenesis, clinical and histopathology presentation, and outcome in IgAN patients. We report four patients with an overlap lesion of IgAN–ANCA positive. Also, we performed a narrative review of all biopsy-proven published case series. Only 1.2% patients had ANCA in our 330-biopsy-proven IgAN cohort. We compared our data with previous reports—6 case series and 3 small retrospective studies—a total of 103 patients. All patients but one had eGFR below 15 mL/min at diagnosis. Besides rapidly decreasing eGFR, all presented with proteinuria around 1.5 g/day and dysmorphic microhematuria, suggesting glomerular inflammation. Systemic symptoms suggestive for ANCA vasculitis were seen in half of our patients, but only one patient had hemorrhagic alveolitis. Patients from our cohort responded to the intensive immunosuppressive regimens used in ANCA-positive vasculitis with renal involvement. However, in the follow-up, one patient had a relapse followed by septic shock related to immunosuppression and one patient started hemodialysis. In the review, we found that IgAN–ANCA -positive patients are characterized by vasculitis-like lesions and clinically by a rapidly progressive decline in kidney function, which was reversed by an aggressive induction immunosuppressive protocol used in ANCA vasculitis. Checking ANCA serology seems useful in patients with rapidly progressive IgAN for therapeutic and prognostic reasons.
Appendix
Available only for authorised users
Literature
4.
go back to reference Sethi S, Haas M, Markowitz GS, D’Agati VD, Rennke HG, Jennette JC, Bajema IM, Alpers CE, Chang A, Cornell LD, Cosio FG, Fogo AB, Glassock RJ, Hariharan S, Kambham N, Lager DJ, Leung N, Mengel M, Nath KA, Roberts IS, Rovin BH, Seshan SV, Smith RJ, Walker PD, Winearls CG, Appel GB, Alexander MP, Cattran DC, Casado CA, Cook HT, De Vriese AS, Radhakrishnan J, Racusen LC, Ronco P, Fervenza FC (2016) Mayo Clinic/Renal Pathology Society consensus report on pathologic classification, diagnosis, and reporting of GN. J Am Soc Nephrol 27(5):1278–1287. https://doi.org/10.1681/ASN.2015060612CrossRefPubMed Sethi S, Haas M, Markowitz GS, D’Agati VD, Rennke HG, Jennette JC, Bajema IM, Alpers CE, Chang A, Cornell LD, Cosio FG, Fogo AB, Glassock RJ, Hariharan S, Kambham N, Lager DJ, Leung N, Mengel M, Nath KA, Roberts IS, Rovin BH, Seshan SV, Smith RJ, Walker PD, Winearls CG, Appel GB, Alexander MP, Cattran DC, Casado CA, Cook HT, De Vriese AS, Radhakrishnan J, Racusen LC, Ronco P, Fervenza FC (2016) Mayo Clinic/Renal Pathology Society consensus report on pathologic classification, diagnosis, and reporting of GN. J Am Soc Nephrol 27(5):1278–1287. https://​doi.​org/​10.​1681/​ASN.​2015060612CrossRefPubMed
7.
go back to reference Allmaras E, Nowack R, Andrassy K, Waldherr R, van der Woude F, Ritz E (1997) Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies benefits from immunosuppression. Clin Nephrol 48(5):269–273PubMed Allmaras E, Nowack R, Andrassy K, Waldherr R, van der Woude F, Ritz E (1997) Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies benefits from immunosuppression. Clin Nephrol 48(5):269–273PubMed
8.
go back to reference O’Donoghue DJ, Nusbaum P, Noel LH, Halbwachs-Mecarelli L, Lesavre P (1992) Antineutrophil cytoplasmic antibodies in IgA nephropathy and Henoch-Schonlein purpura. Nephrol Dial Transplant 7(6):534–538PubMed O’Donoghue DJ, Nusbaum P, Noel LH, Halbwachs-Mecarelli L, Lesavre P (1992) Antineutrophil cytoplasmic antibodies in IgA nephropathy and Henoch-Schonlein purpura. Nephrol Dial Transplant 7(6):534–538PubMed
14.
go back to reference Kelley JM, Monach PA, Ji C, Zhou Y, Wu J, Tanaka S, Mahr AD, Johnson S, McAlear C, Cuthbertson D, Carette S, Davis JC Jr, Dellaripa PF, Hoffman GS, Khalidi N, Langford CA, Seo P, St Clair EW, Specks U, Stone JH, Spiera RF, Ytterberg SR, Merkel PA, Edberg JC, Kimberly RP (2011) IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis. Proc Natl Acad Sci USA 108(51):20736–20741. https://doi.org/10.1073/pnas.1109227109CrossRefPubMed Kelley JM, Monach PA, Ji C, Zhou Y, Wu J, Tanaka S, Mahr AD, Johnson S, McAlear C, Cuthbertson D, Carette S, Davis JC Jr, Dellaripa PF, Hoffman GS, Khalidi N, Langford CA, Seo P, St Clair EW, Specks U, Stone JH, Spiera RF, Ytterberg SR, Merkel PA, Edberg JC, Kimberly RP (2011) IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis. Proc Natl Acad Sci USA 108(51):20736–20741. https://​doi.​org/​10.​1073/​pnas.​1109227109CrossRefPubMed
18.
go back to reference Shimizu M, Wada T, Sakai N, Izumiya Y, Furuichi K, Misaki T, Kobayashi K-I, Goshima S, Takeda S-I, Yokoyama H (2000) Clinicopathological features of antineutrophil cytoplasmic antibodies- associated vasculitis in Japanese patients with IgA nephropathy. Clin Exp Nephrol 4:251–256CrossRef Shimizu M, Wada T, Sakai N, Izumiya Y, Furuichi K, Misaki T, Kobayashi K-I, Goshima S, Takeda S-I, Yokoyama H (2000) Clinicopathological features of antineutrophil cytoplasmic antibodies- associated vasculitis in Japanese patients with IgA nephropathy. Clin Exp Nephrol 4:251–256CrossRef
Metadata
Title
IgA nephropathy with serum ANCA positivity: case series and literature review
Authors
Gabriel Ștefan
George Terinte-Balcan
Simona Stancu
Adrian Zugravu
Mihaela Gherghiceanu
Gabriel Mircescu
Publication date
01-07-2021
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 7/2021
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-021-04888-2

Other articles of this Issue 7/2021

Rheumatology International 7/2021 Go to the issue